TCT 381: Safety and Effectiveness of a Novel Intravascular Lithotripsy Device Using the Hertz Contact Stress Mechanism for Calcium Fragmentation: Six-Month Outcomes of the PINNACLE I Clinical Trial
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Grant Support/Research Contract - Abbott
- Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Boston Scientific Corporation